⌘K
Loading ticker…
As of 2026-08-24, Ascendis Pharma A/S Ordinary Share (ASND) has a 3-month relative strength percentile of 52 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 53. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 3.1%, relative volume 0.61×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No SEC filings on file for this ticker. Fundamentals section requires EDGAR coverage.
ASND is held by 5 ETFs as of May 2026. Top owner: FDG at 2.52% weight, $10M notional. Top 3 carry $24M.
Held by 13 ETFs · $45M across latest filings · largest weight 3.01% (AFOS).
Top 5 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| FDG | 2.52% | $10M | −0.56 pp |
| QQQJ | 0.64% | $7M | new |
| MSSM | 0.88% | $7M | new |
| IBBQ | 1.10% | $740K | new |
| FDG | 0.02% | $69K | −0.56 pp |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ASND Jan avg: 1.42% median: 2.38% win: 75% σ: 4.72% n: 4 2022-04-12 → 2026-07-31 | ASND Feb avg: 6.59% median: 8.50% win: 75% σ: 13.27% n: 4 2022-04-12 → 2026-07-31 | ASND Mar avg: -0.92% median: -1.25% win: 25% σ: 2.48% n: 4 2022-04-12 → 2026-07-31 | ASND Apr avg: -9.52% median: -8.42% win: 40% σ: 16.67% n: 5 2022-04-12 → 2026-07-31 | ASND May avg: 1.55% median: -2.41% win: 20% σ: 12.89% n: 5 2022-04-12 → 2026-07-31 | ASND Jun avg: 7.71% median: 5.99% win: 100% σ: 7.20% n: 5 2022-04-12 → 2026-07-31 | ASND Jul avg: -3.43% median: -2.11% win: 40% σ: 4.58% n: 5 2022-04-12 → 2026-07-31 | ASND Aug avg: 7.28% median: 6.73% win: 100% σ: 3.80% n: 4 2022-04-12 → 2026-07-31 (current) | ASND Sep avg: 5.25% median: 5.09% win: 75% σ: 8.37% n: 4 2022-04-12 → 2026-07-31 | ASND Oct avg: -2.40% median: -1.61% win: 50% σ: 12.17% n: 4 2022-04-12 → 2026-07-31 | ASND Nov avg: 8.89% median: 8.90% win: 100% σ: 3.30% n: 4 2022-04-12 → 2026-07-31 | ASND Dec avg: 6.56% median: 0.80% win: 75% σ: 12.59% n: 4 2022-04-12 → 2026-07-31 |